LAUSR

Background Clinical pharmacists today have modern rolebesides traditional one, which implies supply the hospital pharmacy, as well as ward dispensary with medicine. Today the clinical pharmacist is oriented more towards the patient and pharmaceutical care. Purpose Purpose of this paper is to show the significance of the clinical pharmacist in the rationalisation of pharmacotherapy, including pharmacoeconomic aspects, patient safety and to establish the role of clinical pharmacist in hospital pharmacy. Material and methods Type of research is in retrospective and descriptive character, using preliminary literature on the topic of the paper to get relevant data. Results Implementing the system of unit therapy instead of the traditional system of distribution, by which clinical pharmacist during the preparation of therapy could control drugs dosage, dosage intervals, eventual interaction of drugs, has lead to significant drop of drugs use. Patients with health insurance of Canton Sarajevo during their treatments in hospital facilities have rights to, besides drugs given by Hospital drug list, use drugs from A and B essential drug lists. Drugs in hospital pharmacy have been distributed bythe traditional sum system using order lists for everyward. From year 2015. procedures have been put into function that are going to rationalise pharmacotherapy. Drug use by patient is being documented, which reduces the cost of drugs. Also, preparing and handling reports about issued drugs takes on an important part in rationalisation of pharmacotherapy, because that is the basis to know the exact number of spend tablets per every patient, where the sum spending is documented by every drug onto number of hospitalised patients, in the end relevant data is collected, about price of the spent drug. Conclusion Clinical pharmacists with active involvement in the treatment process, from admission until discharge patients from hospitals, can provide adequate pharmaceutical care, while contributing to the rationalisation of pharmacotherapy, and a significant reduction in costs allocated to treat patients. Using pharmacoecomonical analysis will prove vital to reduce drug use.